Skip
As of yesterday, March 23rd 2017, a new company – AO Kirov Plasma – has been established in Russia to implement the Memorandum of Understanding signed last year by Russian companies National Immunobiological Company (Nacimbio) and Pharmstandard, and by Kedrion Biopharma.
Kedrion has named Andrea Benassi as its representative on the Board of Directors.
You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
